Global Neuroendocrine Tumors (NETs) Market (2024 Edition): Market Insights and Forecast (2020-2030)

Analysis By Therapy (Somatostatin Analogs (SSAs), Targeted Therapy, Others), By Route of Administration, By Indication, By End User, By Region

Published	Pages	Publisher	Report code
Jan 2024	300	Azoth Analytics	ASDR-666911

Published: Jan 2024 - Pages : 300 - Publisher : Azoth Analytics - Report code : ASDR-666911

Novartis
Pfizer
Amgen Inc. GlaxoSmithKline
F. Hoffmann-La Roche AG
Bristol-Myers Squibb Co. Eli Lilly and Company
Ipsen
Lantheus Holdings
and Boehringer Ingelheim

Somatostatin Analogs Market by Type (Lanreotide, Octreotide, Pasireotide), Application (Acromegaly, Neuroendocrine Tumors) - Global Forecast 2023-2030

This report can be of interest as well:

Somatostatin Analogs Market by Type (Lanreotide, Octreotide, Pasireotide), Application (Acromegaly, Neuroendocrine Tumor...

Published: October, 2023 | Report code: ASDR-635820